New algorithm aims to prevent organ rejection in kids
NCT ID NCT07549230
First seen Apr 25, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study will develop a smart dosing tool to help doctors give the right amount of tacrolimus to children after a kidney transplant. The goal is to keep drug levels in a safe range to prevent organ rejection. The study involves 130 children and uses a combination of drug-level data and machine learning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.